Citron Research

U.S. Attorney Bill Essayli slammed Citron Research founder Andrew Left on Tuesday, stating, “Short selling is not a crime. He made misleading statements to move the stock so that he could quickly trade on it for his gain. In essence, he cheated.” In his X post, Essayli said Left was...

Quantum stocks have been on fire this week thanks to World Quantum Day and new announcements from NVIDIA Corporation (NASDAQ:NVDA). When it comes to picking the best quantum stock, Citron Research is doubling down on their pick and telling investors that Nvidia CEO Jensen Huang is also tipping his...

Citron Research has set a massive $300 price target for Amazon.com Inc. (NASDAQ:AMZN), projecting 28% upside from current levels, citing a hidden semiconductor empire that could soon rival the industry leader Nvidia Corp. (NASDAQ:NVDA). ‘Trillion-Dollar’ Threat To Nvidia Following the...

Citron Research, led by Andrew Left, is doubling down on its quantum computing pick, noting that it has successfully transitioned from being a conceptual science project to a commercial reality. This Is No Longer ‘A Science Project’ On Monday, in a post on X, Left reiterated his bullish...

Investor Andrew Left’s Citron Research says a cybersecurity stock is being “deeply mispriced” by investors, while assigning a price target that’s more than double its current levels. This Company ‘Must Be Rerated’ On Thursday, in a post on X, Citron Research made...

Short seller Citron Research, led by Andrew Left, made a prediction one year ago. The firm bet on Bitcoin (CRYPTO: BTC), but against the Bitcoin treasury company Strategy Inc (NASDAQ:MSTR). Here are the results of the trade. Citron Bets Against MicroStrategy Citron Research, best known for betting...

Andrew Left’s Citron Research is calling out a little-known nuclear contractor, which it says is about to become one of the most strategically significant companies in the United States under the Trump administration. The Little-Known Nuclear Contractor On Wednesday, in a post on X, Citron...

Hedge fund manager George Noble posted a bold criticism of Opendoor Technologies, Inc.’s (NASDAQ:OPEN) latest product rollouts in a social media post on Wednesday night.  OPEN stock is moving. See the real-time price action here.  Earlier on Wednesday, Opendoor CEO Kaz Nejatian...

Citron Research, led by famed short-seller Andrew Left, targeted Opendoor Technologies, Inc. (NASDAQ:OPEN) in a social media post on Friday. Opendoor investors shrugged off the attack, and the stock climbed.  OPEN stock is running again. See the real-time chart here.  Citron called Opendoor...

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. Here is a look at the most searched stocks on Benzinga Pro for August 2025 and a look at how the interest compares to...

Palantir Technologies (NASDAQ:PLTR) stock has gained more than 100% year-to-date, hitting new all-time highs in August before a recent pullback. After a short seller questioned the company's valuation, Benzinga polled readers to learn when investors might see all-time highs again. What Happened:...

Wedbush analyst Dan Ives has dubbed Palantir Technologies Inc (NASDAQ:PLTR) the "Messi of AI"—a generational playmaker in the data game, with elite vision and impossible-to-replicate instincts. But even Lionel Messi, widely hailed as the GOAT, can get outpaced by a younger phenom. Enter Databricks...

Palantir Technologies Inc (NASDAQ:PLTR) is soaring like it's invented the next tech miracle — yet the fundamentals tell a very different story. With $412 billion in market cap but only $1.7 billion in free cash flow, even Apple Inc (NASDAQ:AAPL) suddenly looks like a bargain. Track PLTR stock...

UnitedHealth Group (NYSE:UNH) stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings. Among the investors in UnitedHealth Group stock is short seller Andrew Left of Citron Research, who is best known for...

Activist short seller Andrew Left‘s Citron Research has renewed its bearish stance on Duolingo Inc. (NASDAQ:DUOL), citing Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) subsidiary Google’s newly announced artificial intelligence translation technology as a significant threat to the language...